Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Publication year range
1.
ACS Appl Mater Interfaces ; 13(4): 4861-4873, 2021 Feb 03.
Article in English | MEDLINE | ID: mdl-33471499

ABSTRACT

A combination treatment strategy that relies on the synergetic effects of different therapeutic approaches has been considered to be an effective method for cancer therapy. Herein, a chemotherapeutic drug (doxorubicin, Dox) and a manganese ion (Mn2+) were co-loaded into regenerated silk fibroin-based nanoparticles (NPs), followed by the surface conjugation of phycocyanin (PC) to construct tumor microenvironment-activated nanococktails. The resultant PC-Mn@Dox-NPs showed increased drug release rates by responding to various stimulating factors (acidic pH, hydrogen peroxide (H2O2), and glutathione), revealing that they could efficiently release the payloads (Dox and Mn2+) in tumor cells. The released Dox could not only inhibit the growth of tumor cells but also generated a large amount of H2O2. The elevated H2O2 was decomposed into the highly harmful hydroxyl radicals and oxygen through an Mn2+-mediated Fenton-like reaction. Furthermore, the generated oxygen participated in photodynamic therapy (PDT) and produced abundant singlet oxygen. Our investigations demonstrate that these PC-Mn@Dox-NPs exhibit multiple bioresponsibilities and favorable biosafety. By integrating Dox-induced chemotherapy, Mn2+-mediated chemodynamic therapy, and PC-based PDT via cascade reactions, PC-Mn@Dox-NPs achieved enhanced in vitro and in vivo anticancer efficacies compared to all the mono- or dual-therapeutic approaches. These findings reveal that PC-Mn@Dox-NPs can be exploited as a promising nanococktail for cascade reaction-mediated synergistic cancer treatment.


Subject(s)
Antibiotics, Antineoplastic/administration & dosage , Doxorubicin/administration & dosage , Manganese/administration & dosage , Neoplasms/drug therapy , Photosensitizing Agents/administration & dosage , Phycocyanin/administration & dosage , Animals , Antibiotics, Antineoplastic/pharmacology , Antibiotics, Antineoplastic/therapeutic use , Bombyx/chemistry , Cations, Divalent/administration & dosage , Cations, Divalent/pharmacology , Cations, Divalent/therapeutic use , Cell Line, Tumor , Doxorubicin/pharmacology , Doxorubicin/therapeutic use , Drug Carriers/chemistry , Fibroins/chemistry , Glutathione/metabolism , Human Umbilical Vein Endothelial Cells , Humans , Hydrogen-Ion Concentration , Manganese/pharmacology , Manganese/therapeutic use , Mice , Nanoparticles/chemistry , Neoplasms/metabolism , Neoplasms/pathology , Photosensitizing Agents/pharmacology , Photosensitizing Agents/therapeutic use , Phycocyanin/pharmacology , Phycocyanin/therapeutic use , Tumor Microenvironment/drug effects
2.
Eur J Med Chem ; 36(6): 531-8, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11525843

ABSTRACT

Eight dicationic compounds related to pentamidine were studied for trypanocidal activity in seven trypanosome isolates. In vitro studies revealed that diamidines are more potent than diimidazolines. For example, 2 (a diamidine) and 4 (a diimidazoline) inhibited the growth of KETRI 243 with IC50 values of 2.3 and 900 nM, respectively. Introduction of polar groups into the linker decreased the effectiveness of the compounds against drug-resistant trypanosomes. In compounds with a 2-butene linker between the cationic groups, trans-isomers were more potent than cis-isomers. The cis- and trans-buteneamidines cured infection caused by Trypanosoma brucei brucei (EATRO Lab 110) and protected mice against infection by Trypanosoma brucei rhodesiense isolates, some of which are resistant to diamidines and melarsoprol.


Subject(s)
Cations, Divalent/pharmacology , Pentamidine/analogs & derivatives , Pentamidine/pharmacology , Trypanocidal Agents/pharmacology , Trypanosoma brucei brucei/drug effects , Trypanosoma brucei rhodesiense/drug effects , Trypanosomiasis, African/drug therapy , Animals , Cations, Divalent/chemical synthesis , Cations, Divalent/chemistry , Cations, Divalent/therapeutic use , Cattle , DNA/genetics , DNA/metabolism , Drug Design , Drug Evaluation, Preclinical , Female , Inhibitory Concentration 50 , Magnetic Resonance Spectroscopy , Mice , Pentamidine/chemical synthesis , Pentamidine/therapeutic use , Structure-Activity Relationship , Thymus Gland , Trypanocidal Agents/chemical synthesis , Trypanocidal Agents/chemistry , Trypanocidal Agents/therapeutic use
3.
J Eukaryot Microbiol ; 45(1): 112-21, 1998.
Article in English | MEDLINE | ID: mdl-9495040

ABSTRACT

Dicationic diarylfurans and dicationic carbazoles are under development as therapeutic agents against opportunistic infections. While their ability to bind to the minor groove of DNA has been established, the complete mechanism of action has not. We demonstrate here that an effective diarylfuran, 2,5-bis[4-(N-isopropylguanyl)phenyl]furan, inhibits an endo/exonuclease activity present in Pneumocystis carinii, Cryptococcus neoformans, Candida albicans, and Saccharomyces cerevisiae. This activity was purified from the particulate fraction of P. carinii. The enzyme requires Mg++ or Mn++, and shows preferences for single-over double stranded DNA and for AT-rich over GC-rich domains. A panel of 12 dicationic diarylfurans and eight dicationic carbazoles, previously synthesized, were evaluated for inhibition of the purified nuclease and for efficacy against Pneumocystis pneumonia in rats. Among the diarylfurans, potency of nuclease inhibition, in vivo antimicrobial activity, and DNA binding strength were all strongly correlated (p < 0.001). These findings suggest that one target for antimicrobial action of the diarylfurans may be a nucleolytic or other event requiring unpairing of DNA strands. Dicationic carbazoles which were strong nuclease inhibitors all displayed anti-Pneumocystis activity in vivo, but there were also noninhibitory carbazoles with in vivo efficacy.


Subject(s)
Antifungal Agents/therapeutic use , Deoxyribonucleases/antagonists & inhibitors , Pneumocystis/enzymology , Pneumonia, Pneumocystis/drug therapy , Animals , Benzamidines/therapeutic use , Carbazoles/therapeutic use , Cations, Divalent/therapeutic use , Deoxyribonucleases/isolation & purification , Endodeoxyribonucleases/antagonists & inhibitors , Exodeoxyribonucleases/antagonists & inhibitors , Furans/therapeutic use , Hot Temperature , Protein Denaturation , Rats , Substrate Specificity
5.
Trans Am Ophthalmol Soc ; 88: 649-84, 1990.
Article in English | MEDLINE | ID: mdl-2095035

ABSTRACT

A series of ocular HF burns was produced in rabbits in order to clarify the nature of the injury and to provide a description of the animal model. Burned eyes were evaluated clinically and allowed to progress for up to 65 days before histologic examination. The mechanism of HF toxicity was investigated through the study of burns produced by chemicals chosen to mimic its pH effects, osmotic effects, and effects of the free fluoride ion alone. The severe progressive caustic effect of HF on the eyes was found to depend on the combination of pH and the toxic effects of the free fluoride ion, together causing extensive dose-related damage to superficial and deep structures of the eye. Mild burns caused reversible ocular injury; whereas more severe burns lead to corneal stromal scarring, vascularization, edema, formation of calcific band keratopathy plus iris and ciliary body fibrosis. An investigation was made of potential treatments for experimental ocular HF burns in rabbits. Topical ointments containing MgO or MgSO4 and irrigations with or subconjunctival injections of H2O or solutions containing NaCl, MgCl2, CaCl2, LaCl3, hyamine, zephiran, calcium gluconate or a mixture of divalent metal ions were tested for toxicity and for therapeutic value in ocular HF burns. Immediate single irrigation with H2O, NaCl or MgCl2 solution was most effective. Other therapeutic agents commonly used in HF skin burn therapy were either too toxic in normal eyes or caused additive damage to burned eyes.


Subject(s)
Burns, Chemical/physiopathology , Eye Burns/physiopathology , Animals , Anti-Bacterial Agents/therapeutic use , Burns, Chemical/drug therapy , Burns, Chemical/pathology , Cations, Divalent/therapeutic use , Disease Models, Animal , Eye Burns/chemically induced , Eye Burns/drug therapy , Eye Burns/pathology , Hydrofluoric Acid , Ophthalmic Solutions/therapeutic use , Rabbits
6.
Magnesium ; 8(3-4): 154-62, 1989.
Article in English | MEDLINE | ID: mdl-2682041

ABSTRACT

The science of resuscitation has advanced considerably during the past 25 years as a consequence of modern cardiopulmonary resuscitation (CPR). Complete cerebral ischemia for more than 6 min will result in irreversible brain damage in human subjects. However, recent studies suggest that there may be time-dependent therapeutic measures which could improve the neurologic outcome after CPR. These studies suggest that cerebral ischemia is multifactorial in nature and that Ca2+, Mg2+ and Fe2+ ions are important in producing the sequential events which take place at a cellular level. Therefore, a variety of specific and nonspecific calcium entry blockers (e.g. nimodipine, lidoflazine and Mg2+), N-methyl-D-aspartate blockers (e.g. MK-801), and an iron-chelating agent (e.g. deferoxamine) may prove useful as therapeutic agents.


Subject(s)
Brain Ischemia/physiopathology , Cations, Divalent/therapeutic use , Resuscitation/methods , Brain Ischemia/drug therapy , Brain Ischemia/mortality , Humans , Morbidity
7.
Vopr Med Khim ; 25(5): 554-60, 1979.
Article in Russian | MEDLINE | ID: mdl-227171

ABSTRACT

Mineralization of rabbit bone callus was studied within 15 days after resection of the upper part of radius bone inder conditions of treatment with carbostimuline and its mixture with vitamin D3. Content of calcium in the bone regenerate was increased by 40.8% after administration of carbostimuline and--by 70.5% after treatment with mixture containing vitamin D3. These preparations caused only slight effects on the phosphorus content. Dry residue in the regenerate os f animals, treated with the preparations, was increased approximately 2-fold (43% and 23%, respectively, p less than or equal to 0.001) as compared with control group. Content of citric acid was distinctly higher in the bone tissue of the treated animals. Within 15 days after the operation content of sialic acids wanormalized in blood serum of the animals. The data obtained were corroborated by X-ray and histologic examinations.


Subject(s)
Bony Callus/drug effects , Calcification, Physiologic/drug effects , Carbonates/therapeutic use , Cholecalciferol/therapeutic use , Animals , Bony Callus/metabolism , Cations, Divalent/therapeutic use , Citrates/metabolism , Drug Combinations , Drug Evaluation, Preclinical , Magnesium Sulfate , Male , Manganese Compounds , Rabbits , Radius Fractures/drug therapy , Radius Fractures/metabolism , Sialic Acids/metabolism , Time Factors , Wound Healing/drug effects , Zinc Compounds
SELECTION OF CITATIONS
SEARCH DETAIL
...